Herbert A. Fritsche
Chief Tech/Sci/R&D Officer bei Apollon Formularies Plc
Profil
Herbert A.
Fritsche is currently a Non-Executive Director & Chief Science Officer at Apollon Formularies Plc since 2022.
Previously, he worked as the Chief Science Officer at Aion Therapeutic, Inc. from 2020 to 2022.
Before that, he held the position of Director, Chief Scientific Officer & Senior VP at Health Discovery Corp.
from 2010 to 2012.
He also worked as a Director-Clinical Chemistry & Professor at The University of Texas M.D.
Anderson Cancer Center and as a Professor at The University of Texas at Austin.
Additionally, he served as the President of Clinical Ligand Assay Society.
Aktive Positionen von Herbert A. Fritsche
| Unternehmen | Position | Beginn |
|---|---|---|
Apollon Formularies Plc
 Apollon Formularies Plc Pharmaceuticals: OtherHealth Technology Apollon Formularies Plc enganes in the development, market, distribution, and sale of legal hemp and medical cannabis products. It produces pharmaceutical, nutraceutical and other medical cannabis related products, including 3D printed sublingual, suppositories and capsules. Its products include Apollon NAUSEA, Apollon PAIN, Apollon SLEEP, Apollon ANTI-INFLAMMATORY, Apollon SEIZURES, Apollon APPETITE, and Apollon CANCER. The company is headquartered in Negril, Jamaica. | Chief Tech/Sci/R&D Officer | 27.01.2022 |
Ehemalige bekannte Positionen von Herbert A. Fritsche
| Unternehmen | Position | Ende |
|---|---|---|
| AION THERAPEUTIC INC. | Chief Tech/Sci/R&D Officer | 30.06.2022 |
| HEALTH DISCOVERY CORPORATION | Chief Tech/Sci/R&D Officer | 31.12.2012 |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | - |
| Clinical Ligand Assay Society | President | - |
| The University of Texas at Austin | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HEALTH DISCOVERY CORPORATION | Technology Services |
| AION THERAPEUTIC INC. | Health Services |
 | Health Technology |
| Private Unternehmen | 2 |
|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
| Clinical Ligand Assay Society |
